{"id":22887,"date":"2022-04-05T16:17:28","date_gmt":"2022-04-05T15:17:28","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=22887"},"modified":"2022-04-05T16:17:30","modified_gmt":"2022-04-05T15:17:30","slug":"aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/","title":{"rendered":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d&#8217;antibiotiques"},"content":{"rendered":"\n<p>Article publi\u00e9 sur <a href=\"https:\/\/www.zonebourse.com\/cours\/action\/AZIYO-BIOLOGICS-INC-113361402\/actualite\/Aziyo-Biologics-Inc-annonce-la-soumission-a-la-FDA-de-510-k-pour-CanGaroo-RM-son-enveloppe-de-b-39969076\/\" target=\"_blank\" rel=\"noreferrer noopener\">zonebourse.com<\/a> le 04 avril 2022<\/p>\n\n\n\n<p>Aziyo Biologics, Inc. a annonc\u00e9 que la soci\u00e9t\u00e9 avait d\u00e9pos\u00e9 une notification pr\u00e9alable \u00e0 la mise sur le march\u00e9 510(k) aupr\u00e8s de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour l&#8217;enveloppe antibact\u00e9rienne CanGaroo\u00ae RM, son enveloppe biomat\u00e9rielle de nouvelle g\u00e9n\u00e9ration destin\u00e9e \u00e0 \u00eatre utilis\u00e9e avec les dispositifs \u00e9lectroniques implantables (DEI). <\/p>\n\n\n\n<p>Avec cette soumission 510(k), la soci\u00e9t\u00e9 a l&#8217;intention de mettre sur le march\u00e9 am\u00e9ricain une version de son enveloppe CanGaroo existante, approuv\u00e9e par la FDA, am\u00e9lior\u00e9e avec les antibiotiques Rifampin et Minocycline dans des anneaux polym\u00e8res dissolubles. L&#8217;ajout d&#8217;antibiotiques \u00e0 l&#8217;enveloppe de biomat\u00e9riau est con\u00e7u pour r\u00e9duire le risque de colonisation bact\u00e9rienne.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Article publi\u00e9 sur zonebourse.com le 04 avril 2022 Aziyo Biologics, Inc. a annonc\u00e9 que la soci\u00e9t\u00e9 avait d\u00e9pos\u00e9 une notification pr\u00e9alable \u00e0 la mise sur le march\u00e9 510(k) aupr\u00e8s de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour l&#8217;enveloppe antibact\u00e9rienne CanGaroo\u00ae RM, son enveloppe biomat\u00e9rielle de nouvelle g\u00e9n\u00e9ration destin\u00e9e \u00e0 \u00eatre utilis\u00e9e avec les [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":22897,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d&#039;antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d&#039;antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-05T15:17:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-05T15:17:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"862\" \/>\n\t<meta property=\"og:image:height\" content=\"560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d&#8217;antibiotiques\",\"datePublished\":\"2022-04-05T15:17:28+00:00\",\"dateModified\":\"2022-04-05T15:17:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\"},\"wordCount\":152,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\",\"name\":\"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d'antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg\",\"datePublished\":\"2022-04-05T15:17:28+00:00\",\"dateModified\":\"2022-04-05T15:17:30+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg\",\"width\":862,\"height\":560,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d\u2019antibiotiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d'antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/","og_locale":"en_GB","og_type":"article","og_title":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d'antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-04-05T15:17:28+00:00","article_modified_time":"2022-04-05T15:17:30+00:00","og_image":[{"width":862,"height":560,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d&#8217;antibiotiques","datePublished":"2022-04-05T15:17:28+00:00","dateModified":"2022-04-05T15:17:30+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/"},"wordCount":152,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/","name":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d'antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg","datePublished":"2022-04-05T15:17:28+00:00","dateModified":"2022-04-05T15:17:30+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Polymeres.jpg","width":862,"height":560,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/aziyo-biologics-inc-annonce-la-soumission-a-la-fda-de-510k-pour-cangaroo-rm-son-enveloppe-de-biomateriau-de-nouvelle-generation-enrichie-dantibiotiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Aziyo Biologics, Inc. annonce la soumission \u00e0 la FDA de 510(k) pour CanGaroo\u00ae RM, son enveloppe de biomat\u00e9riau de nouvelle g\u00e9n\u00e9ration enrichie d\u2019antibiotiques"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 23:26:59","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22887"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=22887"}],"version-history":[{"count":7,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22887\/revisions"}],"predecessor-version":[{"id":22905,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22887\/revisions\/22905"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/22897"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=22887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=22887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=22887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}